Country: United States
Language: English
Source: NLM (National Library of Medicine)
VERAPAMIL HYDROCHLORIDE (UNII: V3888OEY5R) (VERAPAMIL - UNII:CJ0O37KU29)
NCS HealthCare of KY, Inc dba Vangard Labs
VERAPAMIL HYDROCHLORIDE
VERAPAMIL HYDROCHLORIDE 80 mg
ORAL
PRESCRIPTION DRUG
Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1. Angina at rest including: – Vasospastic (Prinzmetal’s variant) angina – Unstable (crescendo, pre-infarction) angina 2. Chronic stable angina (classic effort-associated angina) Arrhythmias 1. In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS; Accessory Bypass Tract) 2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia Essential Hypertension Verapamil Hydrochloride Tablets are contraindicated in: 1. Severe left ventricular dysfunction (see WARNINGS) 2. Hypotension (systolic pressure less than 90 mm Hg) or cardiogenic shock 3. Sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) 4. Second-or-third-degree AV block (except in patients with a functioning artificial ventricular pacemaker) 5. Patients with atrial flutter or atrial fibrillation and an
Verapamil Hydrochloride Tablets USP, 80 mg white, scored tablets, debossed with WATSON 343 are available in blistercards of 30. Verapamil Hydrochloride Tablets USP, 120 mg white, scored tablets, debossed with WATSON 345 are available in blistercards of 30. Dispense in a tight, light-resistant container with child-resistant closure. Store at 20°-25°C (68°-77°F). [See USP controlled room temperature.] Manufactured By: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed By: Watson Pharma, Inc. Corona, CA 92880 USA Revised: November 2008 1108B 174388
Abbreviated New Drug Application
VERAPAMIL HYDROCHLORIDE- VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED NCS HEALTHCARE OF KY, INC DBA VANGARD LABS ---------- VERAPAMIL HYDROCHLORIDE TABLETS USP REVISED: NOVEMBER 2008 RX ONLY 174388 RX ONLY DESCRIPTION Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets containing 40 mg, 80 mg or 120 mg of verapamil hydrochloride. Verapamil hydrochloride is not chemically related to other cardioactive drugs. The structural formula of verapamil hydrochloride is: Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1- methylethyl)-, monohydrochloride, (±)− Verapamil hydrochloride is a white or practically white, crystalline powder. It is practically odorless and has a bitter taste. It is soluble in water, methanol, and chloroform. The inactive ingredients are anhydrous lactose, corn starch, hypromellose 2910, magnesium stearate, microcrystalline cellulose, polacrilin potassium, and polyethylene glycol 400. In addition the following coloring agents are used: FD&C Yellow No. 6 Aluminum Lake, hydroxypropyl cellulose and titanium dioxide (40 mg light peach, 80 mg light peach and 120 mg peach); hydroxypropyl cellulose and titanium dioxide (40 mg white, 80 mg white and 120 mg white). CLINICAL PHARMACOLOGY Verapamil hydrochloride is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) that exerts its pharmacologic effects by modulating the influx of ionic calcium across the cell membrane of the arterial smooth muscle as well as in conductile and contractile myocardial cells. MECHANISM OF ACTION _ANGINA: _The precise mechanism of action of verapamil hydrochloride as an antianginal agent remains to be fully determined, but includes the following two mechanisms: 1_. Relaxation and prevention of coronary artery spasm:_ Verapamil dilates the main coronary arteries and coronary arterioles, both in normal and ischemic regions, and is a potent inhibi Read the complete document